Craig Kallman Discloses New 6.0% Passive Stake in PAVmed Inc. (PAVM)

On April 3, 2026, Craig Kallman and the Craig Kallman 2015 Living Trust filed a Schedule 13G disclosing a new 6.0% ownership stake in PAVmed Inc. (PAVM). The reporting persons acquired 384,616 shares of common stock, crossing the 5% threshold that triggers a beneficial ownership filing. The transaction that led to this reporting obligation occurred on March 27, 2026. Craig Kallman, a U.S. citizen, is the trustee and controlling person of the New York-based Craig Kallman 2015 Living Trust, which directly holds the shares. Consequently, Mr. Kallman is deemed to have sole voting and dispositive power over the entire position. The filing was made under Rule 13d-1(c), indicating a passive investment intent rather than an attempt to influence or change the control of the issuer. The ownership percentage was calculated based on 6,383,089 shares of PAVmed common stock outstanding as of the issuer's annual report filed on the same date as the triggering event.